Retinoblastoma: diagnosis and management-the UK perspective

被引:33
作者
Jenkinson, Helen [1 ]
机构
[1] Birmingham Childrens Hosp NHS Fdn Trust, Dept Paediat Oncol, Birmingham B4 6NH, W Midlands, England
关键词
INTRAVITREAL CHEMOTHERAPY; RISK-FACTORS; MELPHALAN; BRITAIN; EYE;
D O I
10.1136/archdischild-2014-306208
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
In the developed world, retinoblastoma is an uncommon yet highly curable ocular malignancy of childhood affecting 40-50 children in the UK each year. The presenting signs, most commonly leukocoria and squint, should alert the primary care physician or secondary care physician to examine for the red reflex, the absence of which is an indication for urgent ophthalmology assessment. Diagnosis is made by clinical examination and staging may include bone marrow sampling, lumbar puncture and MRI scanning. CT should be avoided to reduce radiation exposure in a population of whom a proportion are at considerable risk of second malignancies. Although enucleation is necessary for many children, over recent years there has been a growing emphasis on conservative management in an attempt to reduce the need for enucleation and avoid the adverse late effects associated with external beam radiotherapy. This review will describe approaches to treatment in the UK and how the stage, laterality and position of the tumour within the eye influence treatment choices.
引用
收藏
页码:1070 / 1075
页数:6
相关论文
共 20 条
[1]   A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma - Initial results [J].
Abramson, David H. ;
Dunkel, Ira J. ;
Brodie, Scott E. ;
Kim, Jonathan W. ;
Gobin, Y. Pierre .
OPHTHALMOLOGY, 2008, 115 (08) :1398-1404
[2]  
Cancer Research UK, 2014, CANC RES UK CHILDHOO
[3]   Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators [J].
Canturk, S. ;
Qaddoumi, I. ;
Khetan, V. ;
Ma, Z. ;
Furmanchuk, A. ;
Antoneli, C. B. G. ;
Sultan, I. ;
Kebudi, R. ;
Sharma, T. ;
Rodriguez-Galindo, C. ;
Abramson, D. H. ;
Chantada, G. L. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (11) :1432-1436
[4]   Retinoblastoma: Lessons and challenges from developing countries. Ellsworth Lecture 2011 [J].
Chantada, Guillermo L. .
OPHTHALMIC GENETICS, 2011, 32 (04) :196-203
[5]  
Dunkel IJ, 2000, CANCER, V89, P2117, DOI 10.1002/1097-0142(20001115)89:10<2117::AID-CNCR12>3.0.CO
[6]  
2-9
[7]   Lifetime risks of common cancers among retinoblastoma survivors [J].
Fletcher, O ;
Easton, D ;
Anderson, K ;
Gilham, C ;
Jay, M ;
Peto, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (05) :357-363
[8]   Intra-arterial Chemotherapy for the Management of Retinoblastoma Four-Year Experience [J].
Gobin, Y. Pierre ;
Dunkel, Ira J. ;
Marr, Brian P. ;
Brodie, Scott E. ;
Abramson, David H. .
ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (06) :732-737
[9]   Delay in diagnosis of retinoblastoma: risk factors and treatment outcome [J].
Goddard, AG ;
Kingston, JE ;
Hungerford, JL .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (12) :1320-1323
[10]   A study of soft tissue sarcomas after childhood cancer in Britain [J].
Jenkinson, H. C. ;
Winter, D. L. ;
Marsden, H. B. ;
Stovall, M. A. ;
Stevens, M. C. G. ;
Stiller, C. A. ;
Hawkins, M. M. .
BRITISH JOURNAL OF CANCER, 2007, 97 (05) :695-699